In Reply to the Letter to the Editor from Raj et al.: Clinical Evidence Indicates Allogeneic Mesenchymal Stem Cells Do Not Pose a Significant Risk for Cancer Progression in the Context of Cell‐Based Drug Delivery

W. Nathaniel Brennen,Michael T. Schweizer,Hao Wang,Trinity J. Bivalacqua,Alan W. Partin,Su Jin Lim,Carolyn Chapman,Rehab Abdallah,Oren Levy,Neil A. Bhowmick,Jeffrey M. Karp,Angelo De Marzo,John T. Isaacs,Samuel R. Denmeade

STEM CELLS TRANSLATIONAL MEDICINE（2019）

引用 2|浏览35

暂无评分

关键词

Context (language use),Cancer,Mesenchymal stem cell,Letter to the editor,Oncology,Drug delivery,Medicine,Cell based,Clinical evidence,Internal medicine,Significant risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要